SCHEMBL10001166

SCHEMBL10001166

CC(C)(C)C(=O)c1ccccc1C(c1ccc(O)cc1)c1ccc(O)cc1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.66
GAA P10253 1/20 0.66
KMT2A Q03164 1/20 0.66
TDP1 Q9NUW8 1/20 0.66
ESR1 P03372 6/20 0.38
ESR2 Q92731 5/20 0.38
CYP3A4 P08684 3/20 0.38
LIG1 P18858 1/20 0.35
LMNA P02545 2/20 0.34
HSD17B10 Q99714 2/20 0.34
AR P10275 2/20 0.34
TYR P14679 1/20 0.34
HPGD P15428 1/20 0.34
TSHR P16473 1/20 0.34
SLC6A2 P23975 1/20 0.34
SLC6A4 P31645 1/20 0.34
HTR6 P50406 1/20 0.34
ESRRG P62508 1/20 0.34
SLC6A3 Q01959 1/20 0.34
PDCD1 Q15116 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9124130 0.80 ALDH1A1 (0.60) ALDH1A1GAAKMT2ATDP1LMNA
SCHEMBL29636490 0.80 ALDH1A1 (1.00) ALDH1A1GAAKMT2ATDP1ESR1
SCHEMBL438546 0.80 ALDH1A1 (1.00) ALDH1A1GAAKMT2ATDP1ESR1
Phenol SCHEMBL1068767 0.78 ALDH1A1 (0.96) ALDH1A1GAAKMT2ATDP1ESR1
SCHEMBL1507640 0.78 ALDH1A1 (0.96) ALDH1A1GAAKMT2ATDP1ESR1
SCHEMBL10031846 0.77 TDP1 (0.66) ALDH1A1GAAKMT2ATDP1ESR1
SCHEMBL15214044 0.77 GABRA1 (0.45) ALDH1A1KMT2ACYP3A4LMNAHPGD
Potassium Ion SCHEMBL1507637 0.77 ALDH1A1 (0.70) ALDH1A1GAAKMT2ATDP1ESR1
SCHEMBL16018458 0.76 ALDH1A1 (0.84) ALDH1A1GAAKMT2ATDP1LMNA
SCHEMBL22694294 0.76 ALDH1A1 (0.55) ALDH1A1GAAKMT2ATDP1ESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8093427-B2 Construction and screening of solution-phase derived library of fenbufen and ethacrynic acid NATIONAL TSING HUA UNIVERSITY (TW) 2012-01-10 US disclosed
US-8093427-B2 Construction and screening of solution-phase derived library of fenbufen and ethacrynic acid NATIONAL TSING HUA UNIVERSITY (TW) 2012-01-10 US disclosed
US-20110306668-A1 CONSTRUCTION AND SCREENING OF SOLUTION-PHASE DERIVED LIBRARY OF FENBUFEN AND ETHACRYNIC ACID NATIONAL TSING HUA UNIVERSITY (TW) 2011-12-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110306668-A1 CONSTRUCTION AND SCREENING OF SOLUTION-PHASE DERIVED LIBRARY OF FENBUFEN AND ETHACRYNIC ACID CYP4F2, ACR, CYP4F3 ALDH1A1 48/4885GAA 3273/4885KMT2A 4174/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.